Improved Efficacy of a Gene Optimised Adenovirus-based Vaccine for Venezuelan Equine Encephalitis Virus
Open Access
- 31 July 2009
- journal article
- Published by Springer Nature in Virology Journal
- Vol. 6 (1) , 118
Abstract
Background: Optimisation of genes has been shown to be beneficial for expression of proteins in a range of applications. Optimisation has increased protein expression levels through improved codon usage of the genes and an increase in levels of messenger RNA. We have applied this to an adenovirus (ad)-based vaccine encoding structural proteins (E3-E2-6K) of Venezuelan equine encephalitis virus (VEEV). Results: Following administration of this vaccine to Balb/c mice, an approximately ten-fold increase in antibody response was elicited and increased protective efficacy compared to an ad-based vaccine containing non-optimised genes was observed after challenge. Conclusion: This study, in which the utility of optimising genes encoding the structural proteins of VEEV is demonstrated for the first time, informs us that including optimised genes in gene-based vaccines for VEEV is essential to obtain maximum immunogenicity and protective efficacy.Keywords
This publication has 48 references indexed in Scilit:
- CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virusVaccine, 2009
- CpG Used as an Adjuvant for an Adenovirus-Based Venezuelan Equine Encephalitis Virus Vaccine Increases the Immune Response to the Vector, But Not to the Transgene ProductViral Immunology, 2008
- Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccineVaccine, 2008
- An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responsesJournal of Experimental Medicine, 2008
- Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccineVaccine, 2007
- Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infectionVirology, 2007
- Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I, II and IIIVirus Research, 2006
- Optimization of Codon Usage Enhances the Immunogenicity of a DNA Vaccine Encoding Mycobacterial Antigen Ag85BInfection and Immunity, 2005
- Role for mucosal immune responses and cell‐mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus*Journal of Medical Virology, 2002
- Bioterrorism: Implications for the Clinical MicrobiologistClinical Microbiology Reviews, 2001